← Leaderboards
Suneet Agarwal
Boston Children'S Hospital
$6,220,278
Attributed
$6,220,278
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,220,278 · 3
By mechanism
R01$4,358,718 · 1
R33$1,200,060 · 1
K08$661,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Boston Children'S Hospital
Same institution · by research overlap
- Fernando Camargo$19,049,972
- Carla F. Kim$19,225,955
- Teresa V Bowman$4,999,652
- William T Pu$35,812,679
- Alena Yermalovich$509,184
Others in their field
Top investigators on “Hematological Disease”
- Ronald T Mitsuyasu · University Of California Los Angeles$116,828,445
- Rebecca Montalvan · Westat, Inc.$86,600,000
- Stanley Carlton Ahalt · Univ Of North Carolina Chapel Hill$78,409,067
- Paul M. Ridker · Brigham And Women'S Hospital$55,416,022
- Mary M Horowitz · Medical College Of Wisconsin$47,632,939
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
Research focus
Hematological DiseaseCellsStem CellsBaseIn VivoRibonucleoproteinsDyskeratosis CongenitaTelomeraseMutationLongevityComplexBiogenesisAplastic AnemiaPulmonary FibrosisNovel StrategiesCardiovascular DiseasesInnovationGenesDegenerative DisorderHematopoietic Stem CellsLung DiseasesCurative TreatmentsHuman Stem CellsTelomerase Rna Component
Grant awards (17)
Regulation and manipulation of the telomerase RNA component in hematopoiesis$475,725
R01 · FY2025 · DK · contact PI
Regulation and manipulation of the telomerase RNA component in hematopoiesis$456,695
R01 · FY2024 · DK · contact PI
Regulation and manipulation of the telomerase RNA component in hematopoiesis$475,725
R01 · FY2023 · DK · contact PI
Regulation and manipulation of the telomerase RNA component in hematopoiesis$479,272
R01 · FY2022 · DK · contact PI
Novel small molecules to treat degenerative lung and blood diseases$580,560
R33 · FY2021 · HL · contact PI
Regulation and manipulation of the telomerase RNA component in hematopoiesis$480,051
R01 · FY2021 · DK · contact PI
Novel small molecules to treat degenerative lung and blood diseases$619,500
R33 · FY2020 · HL · contact PI
Regulation of the telomerase RNA component in hematopoiesis$398,250
R01 · FY2020 · DK · contact PI
Regulation of the telomerase RNA component in hematopoiesis$398,250
R01 · FY2019 · DK · contact PI
Regulation of the telomerase RNA component in hematopoiesis$398,250
R01 · FY2018 · DK · contact PI
Regulation of the telomerase RNA component in hematopoiesis$398,250
R01 · FY2017 · DK · contact PI
Regulation of the telomerase RNA component in hematopoiesis$398,250
R01 · FY2016 · DK · contact PI
Molecular mechanisms of nuclear reprogramming$132,300
K08 · FY2012 · HL · contact PI
Molecular mechanisms of nuclear reprogramming$132,300
K08 · FY2011 · HL · contact PI
Molecular mechanisms of nuclear reprogramming$132,300
K08 · FY2010 · HL · contact PI
Molecular mechanisms of nuclear reprogramming$132,300
K08 · FY2009 · HL · contact PI
Molecular mechanisms of nuclear reprogramming$132,300
K08 · FY2008 · HL · contact PI